Calibrium
Carmel, Indiana, United States
About Calibrium
Calibrium is an emerging privately-held biopharmaceutical company focused on developing a portfolio of novel drug candidates for the treatment of diabetes and related metabolic diseases. Calibrium was co-founded by Fritz French, Calibrium’s Chief Executive Officer, and Richard DiMarchi, PhD, Calibirum’s Chief Scientific Officer.
Company Facts
- Operating status: Closed
- Company type: For Profit
- IPO status: Private
- Employees: 251 – 500
- Total funding: $3.2M
- Funding stage: M&A
- Last round: Convertible Note (Aug 2015)
- Website: calibrium.com
- Phone: +1 (317)294-3079
Industries & Categories
Biotechnology, Health Care, Health Diagnostics
Canonical: https://fsome.com/organization/calibrium-2510284 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.